Good morning guys,
I'm new to the forum. Age 73+, diagnosed with advanced PCa, Gleason 8, 2 mets in left pelvic lymph nodes plus one in a rib on the left side. I have seen two consultant urologists. Pre CT and bone scans, the first told me that I would be put on hormone therapy plus radiotherapy. After the scan results, a second urologist has put me on bicalutamide for two weeks, after which I will transfer to a LHRH agonist (which, not known) then finish of the bicalutamide to prevent tumor flare. But not a mention of radiotherapy now, although he did say he was referring me to oncology with a view to including me in the Stampede trial.
My questions to all of you who have been or are going through treatment are as follows: As I have read that radiotherapy is shown to benefit those with a low metastatic burden (which I'm assuming mine is as there is no widespread mets), why hasn't this been offered?
Secondly, I am apprehensive about the LHRH treatment as I have read in several sources that it can have adverse effects on the cardiovascular system. I am already on BP medication and several years back I had tachycardia attacks of unknown cause, although metoprolol has kept them luckily under control for many years. Should the urologist take this into account when making the decision for ADT with LHRH?
Your views on these things would be much appreciated.